Aktive Positionen von Hugo Katus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
uniQure GmbH
 uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Gründer | - | - |
AaviGen GmbH
 AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation. | Gründer | - | - |
| Vertrieb & Marketing | - | - |
Karriereverlauf von Hugo Katus
Statistik
International
| Deutschland | 3 |
Operativ
| Founder | 2 |
| Sales & Marketing | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
uniQure GmbH
uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Health Technology |
AaviGen GmbH
AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Hugo Katus
- Erfahrung
